ArticleHaematologica2025

A phase I study of MAGE-A1-targeted T1367 T-cell receptorbased cell therapy in patients with advanced multiple myeloma.

Josefine Krüger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.